Compare MDU Resources Group Inc. Common Stock (Holding Company) (MDU) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MDU Resources Group Inc. Common Stock (Holding Company) vs Vaxcyte Inc. Common Stock — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.92B), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 2.7× MDU Resources Group Inc. Common Stock (Holding Company)'s market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays a 3.03% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| MDU | PCVX | |
|---|---|---|
Market Cap | $3.92B | $10.51B |
Volume | 1,027,656 | 2,644,694 |
Sector | Utilities | Health |
52-Week High | $22.80 | $73.82 |
52-Week Low | $18.39 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.45B | $9.14B |
Dividend Yield | 3.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MDU Resources Group Inc. Common Stock (Holding Company)
MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.
Read more on MDU →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
